Access the full text.
Sign up today, get DeepDyve free for 14 days.
C Cybulski, B Gorski, T Debniak, B Gliniewicz, M Mierzejewski, B Masojc, A Jakubowska, J Matyjasik, E Zlowocka, A Sikorski, SA Narod, J Lubinski (2004)
NBS1 is a prostate cancer susceptibility geneCancer Res, 64
CM Ewing, AM Ray, EM Lange, KA Zuhlke, CM Robbins, WD Tembe, KE Wiley, SD Isaacs, D Johng, Y Wang, C Bizon, G Yan, M Gielzak, AW Partin, V Shanmugam, T Izatt, S Sinari, DW Craig, SL Zheng, PC Walsh, JE Montie, J Xu, JD Carpten, WB Isaacs, KA Cooney (2012)
Germline mutations in HOXB13 and prostate-cancer riskN Engl J Med, 366
R Berry, JJ Schroeder, AJ French, SK McDonnell, BJ Peterson, JM Cunningham, SN Thibodeau, DJ Schaid (2000)
Evidence for a prostate cancer-susceptibility locus on chromosome 20Am J Hum Genet, 67
SJ Hebbring, H Fredriksson, KA White, C Maier, C Ewing, SK McDonnell, SJ Jacobsen, J Cerhan, DJ Schaid, T Ikonen, V Autio, TL Tammela, K Herkommer, T Paiss, W Vogel, M Gielzak, J Sauvageot, J Schleutker, KA Cooney, W Isaacs, SN Thibodeau (2006)
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancerCancer Epidemiol Biomarkers Prev, 15
A Antoccia, J Kobayashi, H Tauchi, S Matsuura, K Komatsu (2006)
Nijmegen breakage syndrome and functions of the responsible protein, NBS1Genome Dyn, 1
DS Lim, ST Kim, B Xu, RS Maser, J Lin, JH Petrini, MB Kastan (2000)
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathwayNature, 404
H Gronberg, L Damber, JE Damber, L Iselius (1997)
Segregation analysis of prostate cancer in Sweden: support for dominant inheritanceAm J Epidemiol, 146
CM Weemaes, TW Hustinx, JM Scheres, PJ Munster, JA Bakkeren, RD Taalman (1981)
A new chromosomal instability disorder: the Nijmegen breakage syndromeActa Paediatr Scand, 70
DJ Schaid, SK McDonnell, ML Blute, SN Thibodeau (1998)
Evidence for autosomal dominant inheritance of prostate cancerAm J Hum Genet, 62
Z Kote-Jarai, S Jugurnauth, S Mulholland, DA Leongamornlert, M Guy, S Edwards, M Tymrakiewitcz, L O’Brien, A Hall, R Wilkinson, AA Al Olama, J Morrison, K Muir, D Neal, J Donovan, F Hamdy, DF Easton, R Eeles (2009)
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancerBr J Cancer, 100
R Varon, C Vissinga, M Platzer, KM Cerosaletti, KH Chrzanowska, K Saar, G Beckmann, E Seemanova, PR Cooper, NJ Nowak, M Stumm, CM Weemaes, RA Gatti, RK Wilson, M Digweed, A Rosenthal, K Sperling, P Concannon, A Reis (1998)
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndromeCell, 93
PC Fong, DS Boss, TA Yap, A Tutt, P Wu, M Mergui-Roelvink, P Mortimer, H Swaisland, A Lau, MJ O’Connor, A Ashworth, J Carmichael, SB Kaye, JH Schellens, JS Bono (2009)
Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriersN Engl J Med, 361
H Li, B Handsaker, A Wysoker, T Fennell, J Ruan, N Homer, G Marth, G Abecasis, R Durbin (2009)
The sequence alignment/map format and SAMtoolsBioinformatics, 25
Z Kote-Jarai, AA Olama, GG Giles, G Severi, J Schleutker, M Weischer, D Campa, E Riboli, T Key, H Gronberg, DJ Hunter, P Kraft, MJ Thun, S Ingles, S Chanock, D Albanes, RB Hayes, DE Neal, FC Hamdy, JL Donovan, P Pharoah, F Schumacher, BE Henderson, JL Stanford, EA Ostrander, KD Sorensen, T Dork, G Andriole, JL Dickinson, C Cybulski, J Lubinski, A Spurdle, JA Clements, S Chambers, J Aitken, RA Gardiner, SN Thibodeau, D Schaid, EM John, C Maier, W Vogel, KA Cooney, JY Park, L Cannon-Albright, H Brenner, T Habuchi, HW Zhang, YJ Lu, R Kaneva, K Muir, S Benlloch, DA Leongamornlert, EJ Saunders, M Tymrakiewicz, N Mahmud, M Guy, LT O’Brien, RA Wilkinson, AL Hall, EJ Sawyer, T Dadaev, J Morrison, DP Dearnaley, A Horwich, RA Huddart, VS Khoo, CC Parker, N As, CJ Woodhouse, A Thompson, T Christmas, C Ogden, CS Cooper, A Lophatonanon, MC Southey, JL Hopper, DR English, T Wahlfors, TL Tammela, P Klarskov, BG Nordestgaard, MA Roder, A Tybjaerg-Hansen, SE Bojesen, R Travis, F Canzian, R Kaaks, F Wiklund, M Aly, S Lindstrom, WR Diver, S Gapstur, MC Stern, R Corral, J Virtamo, A Cox, CA Haiman, L Marchand, L Fitzgerald, S Kolb, EM Kwon, DM Karyadi, TF Orntoft, M Borre, A Meyer, J Serth, M Yeager, SI Berndt, JR Marthick, B Patterson, D Wokolorczyk, J Batra, F Lose, SK McDonnell, AD Joshi, A Shahabi, AE Rinckleb, A Ray, TA Sellers, HY Lin, RA Stephenson, J Farnham, H Muller, D Rothenbacher, N Tsuchiya, S Narita, GW Cao, C Slavov, V Mitev, DF Easton, RA Eeles (2011)
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyNat Genet, 43
JR Smith, D Freije, JD Carpten, H Gronberg, J Xu, SD Isaacs, MJ Brownstein, GS Bova, H Guo, P Bujnovszky, DR Nusskern, JE Damber, A Bergh, M Emanuelsson, OP Kallioniemi, J Walker-Daniels, JE Bailey-Wilson, TH Beaty, DA Meyers, PC Walsh, FS Collins, JM Trent, WB Isaacs (1996)
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide searchScience, 274
E Seemanova (1990)
An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable facies, immunodeficiency and chromosomal instabilityMutat Res, 238
JP Carney, RS Maser, H Olivares, EM Davis, M Beau, JR Yates, L Hays, WF Morgan, JH Petrini (1998)
The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage responseCell, 93
A Liede, BY Karlan, SA Narod (2004)
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literatureJ Clin Oncol, 22
AH Berger, PP Pandolfi (2011)
Haplo-insufficiency: a driving force in cancerJ Pathol, 223
N Bennardo, JM Stark (2010)
ATM limits incorrect end utilization during non-homologous end joining of multiple chromosome breaksPLoS Genet, 6
J Falck, J Coates, SP Jackson (2005)
Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damageNature, 434
BS Carter, TH Beaty, GD Steinberg, B Childs, PC Walsh (1992)
Mendelian inheritance of familial prostate cancerProc Natl Acad Sci USA, 89
E Becker, V Meyer, H Madaoui, R Guerois (2006)
Detection of a tandem BRCT in Nbs1 and Xrs2 with functional implications in the DNA damage responseBioinformatics, 22
G Thomas, KB Jacobs, M Yeager, P Kraft, S Wacholder, N Orr, K Yu, N Chatterjee, R Welch, A Hutchinson, A Crenshaw, G Cancel-Tassin, BJ Staats, Z Wang, J Gonzalez-Bosquet, J Fang, X Deng, SI Berndt, EE Calle, HS Feigelson, MJ Thun, C Rodriguez, D Albanes, J Virtamo, S Weinstein, FR Schumacher, E Giovannucci, WC Willett, O Cussenot, A Valeri, GL Andriole, ED Crawford, M Tucker, DS Gerhard, JF Fraumeni, R Hoover, RB Hayes, DJ Hunter, SJ Chanock (2008)
Multiple loci identified in a genome-wide association study of prostate cancerNat Genet, 40
R Siegel, D Naishadham, A Jemal (2012)
Cancer statistics, 2012CA Cancer J Clin, 62
P Bork, K Hofmann, P Bucher, AF Neuwald, SF Altschul, EV Koonin (1997)
A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteinsFaseb J, 11
I Callebaut, JP Mornon (1997)
From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repairFEBS Lett, 400
RA Eeles, Z Kote-Jarai, AA Al Olama, GG Giles, M Guy, G Severi, K Muir, JL Hopper, BE Henderson, CA Haiman, J Schleutker, FC Hamdy, DE Neal, JL Donovan, JL Stanford, EA Ostrander, SA Ingles, EM John, SN Thibodeau, D Schaid, JY Park, A Spurdle, J Clements, JL Dickinson, C Maier, W Vogel, T Dork, TR Rebbeck, KA Cooney, L Cannon-Albright, PO Chappuis, P Hutter, M Zeegers, R Kaneva, HW Zhang, YJ Lu, WD Foulkes, DR English, DA Leongamornlert, M Tymrakiewicz, J Morrison, AT Ardern-Jones, AL Hall, LT O’Brien, RA Wilkinson, EJ Saunders, EC Page, EJ Sawyer, SM Edwards, DP Dearnaley, A Horwich, RA Huddart, VS Khoo, CC Parker, N As, CJ Woodhouse, A Thompson, T Christmas, C Ogden, CS Cooper, MC Southey, A Lophatananon, JF Liu, LN Kolonel, L Marchand, T Wahlfors, TL Tammela, A Auvinen, SJ Lewis, A Cox, LM FitzGerald, JS Koopmeiners, DM Karyadi, EM Kwon, MC Stern, R Corral, AD Joshi, A Shahabi, SK McDonnell, TA Sellers, J Pow-Sang, S Chambers, J Aitken, RA Gardiner, J Batra, MA Kedda, F Lose, A Polanowski, B Patterson, J Serth, A Meyer, M Luedeke, K Stefflova, AM Ray, EM Lange, J Farnham, H Khan, C Slavov, A Mitkova, G Cao, DF Easton (2009)
Identification of seven new prostate cancer susceptibility loci through a genome-wide association studyNat Genet, 41
J Xu, D Meyers, D Freije, S Isaacs, K Wiley, D Nusskern, C Ewing, E Wilkens, P Bujnovszky, GS Bova, P Walsh, W Isaacs, J Schleutker, M Matikainen, T Tammela, T Visakorpi, OP Kallioniemi, R Berry, D Schaid, A French, S McDonnell, J Schroeder, M Blute, S Thibodeau, H Gronberg, M Emanuelsson, JE Damber, A Bergh, BA Jonsson, J Smith, J Bailey-Wilson, J Carpten, D Stephan, E Gillanders, I Amundson, T Kainu, D Freas-Lutz, A Baffoe-Bonnie, A Aucken, R Sood, F Collins, M Brownstein, J Trent (1998)
Evidence for a prostate cancer susceptibility locus on the X chromosomeNat Genet, 20
A Desai-Mehta, KM Cerosaletti, P Concannon (2001)
Distinct functional domains of nibrin mediate Mre11 binding, focus formation, and nuclear localizationMol Cell Biol, 21
Nibrin (NBN), located on chromosome 8q21 is a gene involved in DNA double-strand break repair that has been implicated in the rare autosomal recessive chromosomal instability syndrome known as Nijmegen Breakage Syndrome (NBS). NBS is characterized by specific physical characteristics (microcephaly and dysmorphic facies), immunodeficiency, and increased risk of malignancy. Individuals who are heterozygous for NBN mutations are clinically asymptomatic, but may display an elevated risk for certain cancers including, but not limited to, ovarian and prostate cancer as well as various lymphoid malignancies. In this study, 94 unrelated familial prostate cancer cases from the University of Michigan Prostate Cancer Genetics Project (n = 54) and Johns Hopkins University (n = 40) were subjected to targeted next-generation sequencing of the exons, including UTRs, of NBN. One individual of European descent, diagnosed with prostate cancer at age 52, was identified to have a heterozygous 2117 C > G mutation in exon 14 of the gene, that results in a premature stop at codon 706 (S706X). Sequencing of germline DNA from additional male relatives showed partial co-segregation of the NBN S706X mutation with prostate cancer. This NBN mutation was not observed among 2768 unrelated European men (1859 with prostate cancer and 909 controls). NBN is involved in double-strand break repair as a component of the MRE11 (meiotic recombination 11)/RAD50/NBN genomic stability complex. The S706X mutation truncates the protein in a highly conserved region of NBN near the MRE11 binding site, thus suggesting a role for rare NBN mutations in prostate cancer susceptibility.
Familial Cancer – Springer Journals
Published: Aug 5, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.